Compliance with hormone replacement therapy: Are women receiving the full impact of hormone replacement therapy preventive health benefits?

Women's Health Issues

Volumn 2, Issue 2, 1992, Pages 75-82

  Ravnikar, Veronica A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ATTITUDE; CARDIOVASCULAR DISEASE; CLIMACTERIUM; ESTROGEN THERAPY; FEMALE; HUMAN; OSTEOPOROSIS; PATIENT COMPLIANCE; PRIMARY HEALTH CARE; TIME; WEIGHT GAIN;

ADULT; AGE FACTORS; AGED; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASES; CLIMACTERIC; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMAN; MIDDLE AGE; OSTEOPOROSIS; PATIENT COMPLIANCE; PRIMARY HEALTH CARE; TIME FACTORS; WEIGHT GAIN;

EID: 0026874818     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1049-3867(05)80275-0     Document Type: Article

References (20)

1. Hip Fracture and the Use of Estrogens in Postmenopausal Women
2. Hormonal prevention and treatment of osteoporosis—state of the art 1990
3. Pathogenesis, prevention, and treatment of osteoporosis.
4. Compliance with hormone therapy
5. Endometrial morphology in asymptomatic women
6. Problem solving in menopausal osteoporosis
7. Bone density in diagnosis of osteoporosis: Thresholds and breakpoints
8. Should prescription of postmenopausal hormone therapy be based on the results of bone densitometry?
9. Physician's judgements about estrogen replacement therapy for menopausal women
10. Hormone replacement therapy acceptability to Nottingham postmenopausal women with a risk factor for osteoporosis
11. Estrogen replacement therapy—a survey of women's knowledge and attitudes
12. Patterns of referral to a menopause clinic
13. A simple method for determining the optimal dosage of progestin in postmenopausal women receiving estrogens
14. Endometrial thickness after menopause: Effect of hormone replacement
15. Assessment of the potency of orally administered progestins in women
16. Amenorrhea and endometrial atrophy with continuous oral estrogen and progesterone therapy in postmenopausal women
17. A randomized double blind placebo controlled, crossover trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapy
18. Enhancing patient compliance with hormone replacement therapy at menopause.
19. Estrogen/gestagen therapy changes soft tissue body composition in postmenopausal women
20. Benign mammographic changes associated with postmenopausal hormone therapy—a longitudinal study